Abstract
Background
Successful renal transplantation has been performed in patients with end-stage renal disease and has been routine in patients with end-stage renal failure for more than two decades. Despite advances in the use of immunosuppressants, there has been only modest improvement in long-term allograft survival. Accumulating data have demonstrated that chronic rejection and recurrent glomerulonephritis are major causes of long-term allograft loss. However, data regarding the long-term impact of posttransplantation glomerulonephritis (PTGN) on ethnic Chinese populations are still unavailable.
Methods
From 1984 to 2010, a total of 268 patients who underwent renal allograft biopsies were reviewed retrospectively. Renal outcomes were compared by Kaplan–Meier analysis, and risk factors for renal survival and all-cause mortality were analyzed using the Cox proportional hazards model.
Results
In all, 85 patients (31.7 %) had PTGN, and the mean time of disease onset was 5.32 ± 5.18 years after transplantation. Among the 85 PTGN cases, 33 (39 %) were immunoglobulin A (IgA) nephropathy, 24 (28 %) were focal segmental glomerulosclerosis, and 8 (9.4 %) were membranous GN. Significant risk was associated with posttransplant IgA GN in hepatitis B virus carriers (odds ratio 5.371, 95 % confidence interval 1.68, 17.19; p = 0.0064). A total of 45 PTGN patients had allograft loss, of whom 49 % had IgA nephropathy. Patients with PTGN had inferior allograft survival rates compared to those with other pathologic findings (p < 0.0003).
Conclusions
Taken together, our results indicate that PTGN had a strong negative impact on long-term kidney graft survival. Posttransplant IgA nephropathy is a leading cause of allograft loss in Chinese kidney transplant patients with PTGN.
Similar content being viewed by others
References
Hume DM, Merrill JP, Miller BF et al (1955) Experiences with renal homotransplantation in the human: report of nine cases. J Clin Invest 34:327–382
Harrison JH, Merrill JP, Murray JE (1956) Renal homotransplantation in identical twins. Surg Forum 6:432–436
Murray JE, Merrill JP, Harrison JH (2001) Renal homotransplantation in identical twins: 1955. J Am Soc Nephrol 12:201–204
Yang H (2006) Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance. Am J Kidney Dis 47:S37–S51
Gaston RS (2006) Current and evolving immunosuppressive regimens in kidney transplantation. Am J Kidney Dis 47:S3–S21
Matas AJ (2006) Recurrent disease after kidney transplantation: it is time to unite to address this problem! Am J Transplant 6:2527–2528
Hariharan S, Johnson CP, Bresnahan BA et al (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605–612
Hariharan S (2001) Long-term kidney transplant survival. Am J Kidney Dis 38:S44–S50
Chadban S (2001) Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 12:394–402
Choy BY, Chan TM, Lai KN (2006) Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 6:2535–2542
Briganti EM, Russ GR, McNeil JJ et al (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347:103–109
Hariharan S, Peddi VR, Savin VJ et al (1998) Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry. Am J Kidney Dis 31:928–931
Ivanyi B (2008) A primer on recurrent and de novo glomerulonephritis in renal allografts. Nat Clin Pract Nephrol 4:446–457
Gaston RS (2009) Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. Clin J Am Soc Nephrol 4:2029–2034
Ponticelli C, Villa M, Cesana B et al (2002) Risk factors for late kidney allograft failure. Kidney Int 62:1848–1854
Kaplan B (2006) Overcoming barriers to long-term graft survival. Am J Kidney Dis 4:S52–S64
Hariharan S, Stablein DE (2005) Improvements in long-term renal transplant graft survival. Am J Transplant 5:630–631
Morzycka M, Croker BP, Siegler HF et al (1982) Evaluation of recurrent glomerulonephritis in kidney allografts. Am J Med 72:588–598
Eckhoff DE, Young CJ, Gaston RS et al (2007) Racial disparities in renal allograft survival: a public health issue? J Am Coll Surg 204:894–902
Chailimpamontree W, Dmitrienko S, Li G et al (2009) Probability, predictors, and prognosis of posttransplantation glomerulonephritis. J Am Soc Nephrol 20:843–851
Racusen LC, Solez K, Colvin RB et al (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713–723
Solez K, Colvin RB, Racusen LC et al (2008) Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8:753–760
Golgert WA, Appel GB, Hariharan S (2008) Recurrent glomerulonephritis after renal transplantation: an unsolved problem. Clin J Am Soc Nephrol 3:800–807
Lai KN, Li PK, Lui SF et al (1991) Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324:1457–1463
Levy M, Chen N (1991) Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80 s. Kidney Int Suppl 35:S24–S33
Lin CY (1991) Clinical features and natural course of HBV-related glomerulopathy in children. Kidney Int Suppl 35:S46–S53
Lai KN, Ho RT, Tam JS et al (1996) Detection of hepatitis B virus DNA and RNA in kidneys of HBV related glomerulonephritis. Kidney Int 50:1965–1977
Lai FM, Lai KN, Tam JS et al (1994) Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens. Am J Surg Pathol 18:175–186
Takeda S, Kida H, Katagiri M et al (1988) Characteristics of glomerular lesions in hepatitis B virus infection. Am J Kidney Dis 11:57–62
Ponticelli C, Traversi L, Feliciani A et al (2001) Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 60:1948–1954
Ponticelli C, Traversi L, Banfi G (2004) Renal transplantation in patients with IgA mesangial glomerulonephritis. Pediatr Transplant 8:334–338
Ponticelli C, Glassock RJ (2010) Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 5:2363–2372
Wang AY, Lai FM, Yu AW et al (2001) Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 38:588–596
Chan TM, Fang GX, Tang CS et al (2002) Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology 36:1246–1252
Lee WC, Wu MJ, Cheng CH et al (2001) Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis 38:1074–1081
Author information
Authors and Affiliations
Corresponding author
Additional information
Kuo-Hsiung Shu and Chi-Yuan Li have equal contribution to this work.
Rights and permissions
About this article
Cite this article
Yu, TM., Wen, MC., Wu, MJ. et al. Impact of Posttransplantation Glomerulonephritis on Long-term Outcome of Kidney Transplants: Single-Center 20-Year Experience. World J Surg 36, 2923–2930 (2012). https://doi.org/10.1007/s00268-012-1759-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-012-1759-x